Search research articles
Contact Us
Filters
Showing results (21-30 of 58) with videos related to
Page
of 6
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
August 19, 2022
The Fraction Size Sensitivity of Late Genitourinary Toxicity: Analysis of Alpha/Beta (α/β) Ratios in the CHHiP Trial
Douglas H Brand, Sarah C Brüningk, Anna Wilkins, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 11, 2023
Gastrointestinal Toxicity Prediction Not Influenced by Rectal Contour or Dose-Volume Histogram Definition
Douglas H Brand, Sarah C Brüningk, Anna Wilkins, et al.
Anticancer Research
|
August 5, 2010
Metastatic breast cancer presenting as a primary hindgut neuroendocrine tumour
Alicia F C Okines, Eliza A Hawkes, Sheela Rao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 30, 2019
Patterns of recurrence after prostate bed radiotherapy
Douglas H Brand, Joanna I Parker, David P Dearnaley, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 7, 2021
Estimates of Alpha/Beta (α/β) Ratios for Individual Late Rectal Toxicity Endpoints: An Analysis of the CHHiP Trial
Douglas H Brand, Sarah C Brüningk, Anna Wilkins, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 13, 2026
2-year outcomes of the SPARC phase II trial: Simultaneous focal boost with stereotactic radiotherapy for localised intermediate to high-risk prostate cancer
Binnaz Yasar, Yae-Eun Suh, Ewan Chapman, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 18, 2024
Simultaneous Focal Boost With Stereotactic Radiation Therapy for Localized Intermediate- to High-Risk Prostate Cancer: Primary Outcomes of the SPARC Phase 2 Trial
Binnaz Yasar, Yae-Eun Suh, Ewan Chapman, et al.
European Urology
|
July 21, 2015
Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence: A Multi-institutional Analysis
Piet Ost, Barbara Alicja Jereczek-Fossa, Nicholas Van As, et al.
Frontiers in Oncology
|
June 3, 2022
Oligoprogression in Metastatic, Castrate-Resistant Prostate Cancer-Prevalence and Current Clinical Practice
Priyanka H Patel, Nina Tunariu, Daniel S Levine, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 14, 2025
Dose-response modelling of stereotactic radiosurgery for brain metastases: Preliminary prospective data from the SAFER study (IRAS 276567)
James de Boisanger, Amina Tran, Philip Benjamin, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 58) with videos related to
Sort By:
Page
of 6
International Journal of Radiation Oncology, Biology, Physics
|
August 19, 2022
The Fraction Size Sensitivity of Late Genitourinary Toxicity: Analysis of Alpha/Beta (α/β) Ratios in the CHHiP Trial
Douglas H Brand, Sarah C Brüningk, Anna Wilkins, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 11, 2023
Gastrointestinal Toxicity Prediction Not Influenced by Rectal Contour or Dose-Volume Histogram Definition
Douglas H Brand, Sarah C Brüningk, Anna Wilkins, et al.
Anticancer Research
|
August 5, 2010
Metastatic breast cancer presenting as a primary hindgut neuroendocrine tumour
Alicia F C Okines, Eliza A Hawkes, Sheela Rao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 30, 2019
Patterns of recurrence after prostate bed radiotherapy
Douglas H Brand, Joanna I Parker, David P Dearnaley, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 7, 2021
Estimates of Alpha/Beta (α/β) Ratios for Individual Late Rectal Toxicity Endpoints: An Analysis of the CHHiP Trial
Douglas H Brand, Sarah C Brüningk, Anna Wilkins, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 13, 2026
2-year outcomes of the SPARC phase II trial: Simultaneous focal boost with stereotactic radiotherapy for localised intermediate to high-risk prostate cancer
Binnaz Yasar, Yae-Eun Suh, Ewan Chapman, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 18, 2024
Simultaneous Focal Boost With Stereotactic Radiation Therapy for Localized Intermediate- to High-Risk Prostate Cancer: Primary Outcomes of the SPARC Phase 2 Trial
Binnaz Yasar, Yae-Eun Suh, Ewan Chapman, et al.
European Urology
|
July 21, 2015
Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence: A Multi-institutional Analysis
Piet Ost, Barbara Alicja Jereczek-Fossa, Nicholas Van As, et al.
Frontiers in Oncology
|
June 3, 2022
Oligoprogression in Metastatic, Castrate-Resistant Prostate Cancer-Prevalence and Current Clinical Practice
Priyanka H Patel, Nina Tunariu, Daniel S Levine, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 14, 2025
Dose-response modelling of stereotactic radiosurgery for brain metastases: Preliminary prospective data from the SAFER study (IRAS 276567)
James de Boisanger, Amina Tran, Philip Benjamin, et al.
Page
of 6